We’re the leading resource for those affected by bleeding disorders. You can count on our organization to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.
Thanks to the Nagel Foundation and their generous support of NHF Idaho.
The study focused on disparities associated with bleeding symptoms, age at diagnosis and provider interventions for females with bleeding disorders.
Novo Nordisk recently announced that they have submitted a Biologics License Applications (BLA) to the U.S. Food and Drug Administration for N8-GP (tuco-tuco alfa pegol), a recombinant, extended half-life factor VIII (FVIII) product intended for the prevention and treatment of bleeding in people with hemophilia A.
If you or someone you care for had contact with an HTC in 2017, your feedback is needed!
Barry Haarde was a cyclist and community activist whose strength will never be forgotten.
Subscribe to Our Newsletter
Fill in the fields below to receive our email newsletter.